Enanta Pharmaceuticals Reports Financial Results for its Fourth Quarter and Year Ended September 30, 2017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. ACN
10. USO

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fourth Quarter and Year Ended September 30, 2017

Enanta Pharma (ENTA) Misses Q4 EPS by 27c

November 20, 2017 4:02 PM EST

Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of $1.86, $0.27 worse than the analyst estimate of $2.13. Revenue for the quarter came in at $75.9 million versus the consensus estimate of $73.12 million.

Financial Guidance for Fiscal Year Ending September 30, 2018

Research and development expense between $90 million and $110... More